Previous 10 | Next 10 |
Looking For Cheap Penny Stocks? How Do These Stack up? Penny stocks come in all shapes and sizes. Whether you’re simply looking for stocks under $5 or maybe you’re more specific to penny stocks under 10 cents, there’s something for everyone. In fact, there are even stock...
What Do Analysts Think About These Penny Stocks To Buy For Less Than $3? As the saying goes with penny stocks : just because they’re low-priced doesn’t mean they’re “cheap”. This is a distinction new traders won’t understand until they find penny sto...
A Quick List Of Penny Stocks To Watch This Month Markets are looking to extend gains from last week and penny stocks are part of the mix. There were plenty of sectors heading toward new highs last week including technology and healthcare. However, coronavirus cases remain a sticking point fo...
Aeterna Zentaris (NASDAQ: AEZS ) : Q2 GAAP EPS of -$0.15. More news on: Aeterna Zentaris Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
– Positive results from AEZS-130-P01 (“Study P01”) confirmed dosing regimen of macimorelin as a potential diagnostic for childhood-onset growth hormone deficiency – Safety and efficacy study AEZS-130-P02 (“Study P02”) expected to commence...
CHARLESTON, S.C., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc . (NASDAQ: AEZS; TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, announced today the closing of its previously anno...
Aeterna Zentaris ( AEZS -10.2% ) has entered into a securities purchase agreement for ~12.4M shares at $0.56325/share in a registered direct offering, for gross proceeds of ~$7M More news on: Aeterna Zentaris Inc., Healthcare stocks news, , Stocks on the move, Read more ....
CHARLESTON, S.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, announced today that it has entered into a securi...
CHARLESTON, S.C., July 31, 2020 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced the filing...
CHARLESTON, S.C., July 30, 2020 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that the abstract on study resul...
News, Short Squeeze, Breakout and More Instantly...
Aeterna Zentaris Inc. Company Name:
AEZS Stock Symbol:
NASDAQ Market:
Aeterna Zentaris Inc. Website:
2024-07-17 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for he...
Aeterna Zentaris Inc. (NASDAQ: AEZS) is one of today's top gainers. The company's shares have moved 24.97% on the day to $6.7. Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimore...